Certolizumab Pegol
Showing 1 - 25 of 200
Rheumatoid Arthritis Trial in United States (Certolizumab pegol)
Completed
- Rheumatoid Arthritis
- Certolizumab pegol
-
Covina, California
- +8 more
Jul 26, 2022
Polyarticular-course Juvenile Idiopathic Arthritis (JIA) Trial in Worldwide (Certolizumab Pegol (CZP))
Active, not recruiting
- Polyarticular-course Juvenile Idiopathic Arthritis (JIA)
- Certolizumab Pegol (CZP)
-
Little Rock, Arkansas
- +35 more
Dec 1, 2022
Axial Spondyloarthritis Trial (Tapered doses of TNFi, Standard dose of TNFi)
Recruiting
- Axial Spondyloarthritis
- Tapered doses of TNFi
- Standard dose of TNFi
-
Toronto, Ontario, CanadaUniversity Health Network - Toronto Western Hospital
Nov 21, 2022
Crohn's Disease Trial (Certolizumab pegol, Adalimumab, Placebo)
Withdrawn
- Crohn's Disease
- Certolizumab pegol
- +2 more
- (no location specified)
Jun 17, 2021
TofAcitinib in Routine Care Rheumatoid Arthritis-Cancer
Completed
- Rheumatoid Arthritis
- Tofacitinib
- TNF Inhibitor
-
Boston, MassachusettsBrigham And Women's Hospital
Jun 17, 2022
Moderate to Severe Psoriasis, Generalized Pustular Psoriasis and Erythrodermic Psoriasis Trial in Japan (Placebo, Certolizumab
Completed
- Moderate to Severe Psoriasis
- Generalized Pustular Psoriasis and Erythrodermic Psoriasis
- Placebo
- Certolizumab Pegol
-
Asahikawa, Japan
- +32 more
Dec 13, 2021
Assess How Well Certolizumab Pegol Works in Moderate to Severe
Completed
- Plaque Psoriasis
- Certolizumab pegol
-
Brussels, Belgium
- +78 more
Jan 20, 2023
TofAcitinib in Routine Care Rheumatoid Arthritis- Cardiovascular
Completed
- Rheumatoid Arthritis
- Tofacitinib
- TNF Inhibitor
-
Boston, MassachusettsBrigham And Women's Hospital
Mar 1, 2022
Psoriatic Arthritis, Withdrawal, Reduction Trial in Erlangen (Prednisolone, Sulfasalazine, Leflunomide)
Recruiting
- Psoriatic Arthritis
- +2 more
- Prednisolone
- +14 more
-
Erlangen, Bavaria, GermanyUniversitätsklinikum Erlangen
Nov 10, 2022
Rheumatoid Arthritis Trial (Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD))
Not yet recruiting
- Rheumatoid Arthritis
- Discontinuation of biological/targeted synthetic disease modifying anti-rheumatic drug (b/tsDMARD)
- (no location specified)
Nov 12, 2021
Axial Spondyloarthritis (axSpA), Anterior Uveitis (AU) Trial in Worldwide (Certolizumab Pegol)
Completed
- Axial Spondyloarthritis (axSpA)
- Anterior Uveitis (AU)
- Certolizumab Pegol
-
Brno, Czechia
- +22 more
Jan 20, 2021
Axial Spondyloarthritis, Nonradiographic Axial Spondyloarthritis, Nr-axSpA Trial in Worldwide (Certolizumab Pegol, Placebo)
Completed
- Axial Spondyloarthritis
- +2 more
- Certolizumab Pegol
- Placebo
-
Birmingham, Alabama
- +104 more
Aug 16, 2022
UCB Cimzia Pregnancy Follow-up Study
Terminated
- Rheumatoid Arthritis (RA)
- +3 more
-
Wilmington, North CarolinaUp0019 001
Apr 19, 2021
OTIS Autoimmune Diseases in Pregnancy Project
Recruiting
- Crohn's Disease
- +4 more
-
San Diego, CaliforniaUniversity of California, San Diego
Apr 1, 2021
Crohn's Disease Trial in Japan (Certolizumab Pegol, Placebo)
Completed
- Crohn's Disease
- Certolizumab Pegol
- Placebo
-
Aichi-Gun, Aichi, Japan
- +21 more
Jul 14, 2020
Psoriasis, Plaque Psoriasis Trial in Worldwide (Certolizumab Pegol, Etanercept, Placebo)
Completed
- Psoriasis
- Plaque Psoriasis
- Certolizumab Pegol
- +2 more
-
Mobile, Alabama
- +69 more
Jul 15, 2021
Rheumatoid Arthritis Trial in Chicago (Lab Work, Certolizumab pegol (CDP870, tradename Cimzia)(prefilled syringes at the dose of
Completed
- Rheumatoid Arthritis
- Lab Work
- +11 more
-
Chicago, IllinoisOutpatient Care Center
Jul 13, 2020
Rheumatoid Arthritis, Pregnancy Related Trial in Shanghai (Certolizumab Pegol 200 MG/ML [Cimzia], Hydroxychloroquine,
Not yet recruiting
- Rheumatoid Arthritis
- Pregnancy Related
- Certolizumab Pegol 200 MG/ML [Cimzia]
- +2 more
-
Shanghai, Shanghai, ChinaRenji Hospital
Sep 29, 2020
Rheumatoid Arthritis Trial in Worldwide (Certolizumab Pegol)
Completed
- Rheumatoid Arthritis
- Certolizumab Pegol
-
Montgomery, Alabama
- +70 more
Nov 26, 2020
Rheumatoid Arthritis Trial in Germany, Portugal, Serbia (Certolizumab Pegol, Placebo)
Completed
- Rheumatoid Arthritis
- Certolizumab Pegol
- Placebo
-
Berlin, Germany
- +5 more
Mar 9, 2020
Rheumatoid Arthritis Trial in Worldwide (Certolizumab pegol (CDP870))
Completed
- Rheumatoid Arthritis
- Certolizumab pegol (CDP870)
-
Huntsville, Alabama
- +78 more
Nov 26, 2020
National Data Bank for Rheumatic Disease Registry Study of
Completed
- Rheumatoid Arthritis
- (no location specified)
Jul 15, 2020
Stage IV Lung Adenocarcinoma Trial in United States (Certolizumab, cisplatin, pemetrexed)
Completed
- Stage IV Lung Adenocarcinoma
- Certolizumab
- +2 more
-
Basking Ridge, New Jersey
- +5 more
Jan 25, 2023